Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA's Benefit-Risk Assessment Could Include More Emphasis on Patient Involvement
May 29 2019
•
By
Brenda Sandburg
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from Pathways & Standards